Join
Live feed
·
PRReleasevia Quantisnow
Journey Medical Corporation logo
Fortress Biotech Inc. logo

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

ByQuantisnow·Wall Street's wire, on your screen.
DERM· Journey Medical CorporationFBIO· Fortress Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DERM (Journey Medical Corporation), FBIO (Fortress Biotech Inc.) and more on Quantisnow.

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc. | Quantisnow